These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29143105)

  • 1. Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index.
    Sun M; Cheng J; Zhang Y; Bai J; Wang F; Meng Y; Li Z
    Eur Radiol; 2018 Apr; 28(4):1701-1708. PubMed ID: 29143105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
    Mosavi F; Wassberg C; Selling J; Molin D; Ahlström H
    Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
    Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
    J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT.
    Baranska D; Matera K; Podgorski M; Gorska-Chrzastek M; Krajewska K; Trelinska J; Grzelak P
    MAGMA; 2019 Jun; 32(3):381-390. PubMed ID: 30498885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
    Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
    Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
    Stéphane V; Samuel B; Vincent D; Joelle G; Remy P; Francois GG; Jean-Pierre T
    Eur J Radiol; 2013 Nov; 82(11):2011-7. PubMed ID: 23932096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
    Maggialetti N; Ferrari C; Minoia C; Asabella AN; Ficco M; Loseto G; De Tullio G; de Fazio V; Calabrese A; Guarini A; Rubini G; Brunese L
    Radiol Med; 2016 Feb; 121(2):132-43. PubMed ID: 26349573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Knogler T; Sillaber C; Jaeger U; Simonitsch-Klupp I; Ubl P; Müllauer L; Dolak W; Lukas J; Raderer M
    Clin Cancer Res; 2015 Jun; 21(11):2506-13. PubMed ID: 25733598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body diffusion-weighted imaging with background body signal suppression and quantitative apparent diffusion coefficient in the detection, staging, and grading of non-Hodgkin lymphoma.
    Razek AAKA; Tawfik AM; Rahman MA; Teima S; Batouty NM
    Pol J Radiol; 2023; 88():e177-e186. PubMed ID: 37057202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
    De Paepe KN; De Keyzer F; Wolter P; Bechter O; Dierickx D; Janssens A; Verhoef G; Oyen R; Vandecaveye V
    J Magn Reson Imaging; 2018 Oct; 48(4):897-906. PubMed ID: 29656584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
    Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M
    Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
    Mori N; Ota H; Mugikura S; Takasawa C; Ishida T; Watanabe G; Tada H; Watanabe M; Takase K; Takahashi S
    Radiology; 2015 Jan; 274(1):66-73. PubMed ID: 25203132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Assessment of Bladder Cancer Reflects Grade and Recurrence: Comparing of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
    Li H; Liu L; Ding L; Zhang Z; Zhang M
    Acad Radiol; 2019 Sep; 26(9):1148-1153. PubMed ID: 30503834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial carcinoma: diffusion-weighted imaging diagnostic accuracy and correlation with Ki-67 expression.
    Jiang JX; Zhao JL; Zhang Q; Qing JF; Zhang SQ; Zhang YM; Wu XH
    Clin Radiol; 2018 Apr; 73(4):413.e1-413.e6. PubMed ID: 29246587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of apparent diffusion coefficient with Ki-67 in the diagnosis of gliomas.
    Yin Y; Tong D; Liu XY; Yuan TT; Yan YZ; Ma Y; Zhao R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):503-8. PubMed ID: 23134828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Bowel Preparation on ADC Measurements: Comparison between Conventional DWI and DWIBS Sequences.
    Apine I; Baduna M; Pitura R; Pokrotnieks J; Krumina G
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31330916
    [No Abstract]   [Full Text] [Related]  

  • 17. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients.
    Atkinson W; Catana C; Abramson JS; Arabasz G; McDermott S; Catalano O; Muse V; Blake MA; Barnes J; Shelly M; Hochberg E; Rosen BR; Guimaraes AR
    Abdom Radiol (NY); 2016 Jul; 41(7):1338-48. PubMed ID: 27315095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of apparent diffusion coefficient with Ki-67 proliferation index in meningiomas.
    Baskan O; Silav G; Bolukbasi FH; Canoz O; Geyik S; Elmaci I
    Br J Radiol; 2016; 89(1057):20140842. PubMed ID: 26537690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging of prostate cancer on 3T MR: Relationship between apparent diffusion coefficient values and Ki-67 expression.
    Zhang J; Jing H; Han X; Huang Z; Cao Z; Liu Q
    Acad Radiol; 2013 Dec; 20(12):1535-41. PubMed ID: 24200480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.